TABLE 39A LIST OF PUBLICATIONS REFERRED TO IN THE ...

1.925 Koning S et al. Interventions for impetigo. Cochrane Database Syst Rev 2003;2:CD003261.
1.926 Koning S et al. Interventions for impetigo. Cochrane Database Syst Rev 2003;2:CD003261.
1.927 Filbin MR et al. Case 2-2009: A 25-year-old man with pain and swelling of the right hand and hypotension.
N Engl J Med 2009;360:281-90.
1.928 Anaya DL et al. Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis 2007;
44:705-10.
1.929 Hasham S et al. Necrotising fasciitis. Br Med J 2005;330:830-3.
1.930 Young MH et al. Necrotizing fasciitis: pathogenesis and treatment. Expert Rev Anti Infect Ther
2005;3:279-94.
1.931 Brown-Elliott BA et al. Clinical and laboratory features of the Nocardia spp. based on current molecular
taxonomy. Clin Microbiol Rev 2006;19:259-82.
1.932 Jodlowski TZ et al. Linezolid for the treatment of Nocardia spp. infections. Ann Pharmacother 2007;
41:1694-9.
1.933 Crum-Cianflone MF. Bacterial, fungal, parasitic and viral myositis. Clin Microbiol Rev 2008;21:473-
94.
1.934 Small LN et al. Tropical and temporate pyomyositis. Infect Dis Clin North Am 2005;19:981-9.
1.935 Stanley JR et al. Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome. N
Engl J Med 2006;355:1800-10.
1.936 Patel GK. Treatment of staphylococcal scalded skin syndrome. Expert Rev Anti Infect Ther 2004;2:
575-87.
1.937 Johnston GA. Treatment of bullous impetigo and the staphylococcal scalded skin syndrome. Expert
Rev Anti Infect Ther 2004;2:439-46.
1.938 Zeegelaar JE et al. Imported tropical ulcers in travelers. Am J Clin Dermatol 2008;9:219-32.
1.939 Singer AJ et al. Current management of acute cutaneous wounds. N Engl J Med 2008;359:1037-46.
1.940 Nichols RL et al. Clinical presentations of soft-tissue infections and surgical site infections. Clin Infect
Dis 2001;33(suppl. 2):S84-93.
1.941 Moran GJ et al. Antimicrobial prophylaxis for wounds and procedures in the emergency department.
Infect Dis Clin North Am 2008;22:117-43.
1.942 Zalavras CG et al. Management of open fractures. Infect Dis Clin North Am 2005;19:915-29.
1.943 Nakamuro Y et al. Use of appropriate antimicrobials in wound management. Emerg Med Clin North
Am 2007;25:159-76.
1.944 Leaper D et al. Prevention and treatment of surgical site infection: summary of NICE guidance. Br
Med J 2008;337:1049-51.
1.945 Nichols RL et al. Clinical presentations of soft-tissue infections and surgical site infections. Clin Infect
Dis 2001;33(suppl. 2):S84-93.
1.946 Thompson C et al. Coinfecting deer-associated zoonoses: Lyme disease, babesiosis, and ehrlichiosis.
Clin Infect Dis 2001;33:676-85.
1.947 Krause PJ et al. Disease specific diagnosis of coinfecting tickborne zoonoses: babesiosis, human
granulocytic ehrlichiosis, and Lyme disease. Clin Infect Dis 2002;34:1184-91.
1.948 Centers for Disease Control and Prevention (CDC). Diagnosis and management of tickborne rickettsial
diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis. Morb Mortal Wkly
Rep 2006;55(RR-4):1-27.
1.949 Swanson SJ et al. Coinfections acquired from Ixodes ticks. Clin Microbiol Rev 2006;19:708-27.
1.950 Heyman P et al. A clear and present danger: tick-borne diseases in Europe. Expert Rev Anti Infect
Ther 2010;8:33-50.
1.951 Jensenius M et al. Threats to international travellers posed by tick-borne diseases. Travel Med Infect
Dis 2006;4:4-13.
1.952 Centers for Disease Control and Prevention (CDC). Diagnosis and management of tickborne rickettsial
diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis. Morb Mortal Wkly
Rep 2006;55(RR-4):1-27.
1.953 Foucault C et al. Bartonella quintana characteristics and clinical management. Emerg Infect Dis
2006;12:217-23.
1.954 Wormser GP. Discovery of new infectious diseases: Bartonella species. N Engl J Med 2007;356:
2346-7.
1.955 Rolain JM et al. Recommendations for treatment of human infections caused by Bartonella species.
Antimicrob Agents Chemother 2004;48:1921-33.
1.956 Wormser GP. Discovery of new infectious diseases: Bartonella species. N Engl J Med 2007;356:
2346-7.
1.957 Eremeeva ME et al. Bacteremia, fever, and splenomegaly caused by a newly recognized Bartonella
species. N Engl J Med 2007;357:2381-7.
1958 Al-Tawfiq JA. Therapeutic options for human brucellosis. Expert Rev Anti Infect Ther 2008;6:109-
20.
1.959 Skalsky K et al. Treatment of human brucellosis: systematic review and meta-analysis of randomised
controlled trials. Br Med J 2008;336:701-4.
1.960 Franco MP et al. Human brucellosis. Lancet Infect Dis 2007;7:775-86.
1.961 Mesner O et al. The many faces of human-to-human transmission of brucellosis: congenital infection
and outbreak of nosocomial disease related to an unrecognized clinical case. Clin Infect Dis 2007;
45:e135-40.
1.962 Pappas G et al. Brucellosis. N Engl J Med 2005;352:2325-36.
1.963 Lim ML et al. Brucellosis. Infect Dis Clin Pract 2004;12:7-14.
1.964 Solera J et al. A randomized, double-blind study to assess the optimal duration of doxycycline treatment
for human brucellosis. Clin Infect Dis 2004;39:1176-82.
1.965 Falagas ME et al. Quinolones for treatment of human brucellosis: critical review of the evidence from
microbiological and clinical studies. Antimicrob Agents Chemother 2006;50:22-33.
1.966 Pappas G et al. Quinolones for brucellosis: treating old diseases with new drugs. Clin Microbiol
Infect 2006;12:823-5.
1.967 Solera J et al. Brucellar spondylitis: review of 35 cases and literature survey. Clin Infect Dis 1999;29:
1440-9.
1.968 Colmenero JD et al. Clinical findings, therapeutic approach and outcome of brucellar vertebral osteomyelitis.
Clin Infect Dis 2008;46:426-33.
1.969 Wormser GP et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic
anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society
of America. Clin Infect Dis 2006;43:1089-134.